Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis

Ophthalmology. 1984 Dec;91(12):1592-602. doi: 10.1016/s0161-6420(84)34113-6.

Abstract

The visual prognosis of 148 eyes in patients with an active subfoveal or juxtafoveal subretinal neovascular membrane (SRNVM) in the presumed ocular histoplasmosis syndrome (POHS) was reviewed. Average follow-up was 39 months. One hundred twenty of 148 eyes (81.1%) had a final visual acuity worse than 20/40. One hundred three of 148 eyes (69.6%) had a final visual acuity equal to or worse than 20/200. Systemic and/or periocular steroids had no effect on final visual outcome. Factors affecting final visual outcome are described and prognosis in the fellow eye is discussed.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Choroiditis / drug therapy
  • Choroiditis / physiopathology*
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Histoplasmosis / drug therapy
  • Histoplasmosis / physiopathology*
  • Humans
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / physiopathology*
  • Prognosis
  • Retinal Vessels*
  • Steroids / therapeutic use
  • Syndrome
  • Visual Acuity* / drug effects

Substances

  • Steroids